About ADePT

ADePT was formed in 2020 as a joint project between Greater Manchester Mental Health (GMMH) and the metacognitive therapy research group led by Professor Wells at the University of Manchester.

The Anxiety, Depression and Psychological Therapies Research Unit (ADePT-RU) conducts cutting-edge, evidenced-based research aiming to improve our understanding and treatment of mental health disorders in adults and children. Currently our research is testing treatments for anxiety and depression in patients with cardiovascular disease, and treating anxiety and depression in burns and plastic surgery patients, evaluating home-based therapies, and transdiagnostic group therapy approaches in adults and young people.

To make our research happen we work with a range of leading academic and clinical partners along with patients and members of the public to ensure our research is in line with patient’s needs and provides direct patient benefits.

Get in touch

Unit Director: Professor Adrian Wells

Consultant Clinical Psychologist, GMMH

Professor of Clinical & Experimental Psychopathology, University of Manchester

  • MCT-PATHWAY

    The MCT Pathway programme ran from 2014 to 2021. Its goal was to improve the health and quality of life of heart disease patients and to reduce the risk of further cardiac events through cardiac rehabilitation services.

    More information

  • Youth Metcognitive Therapy (YoMeta)

    The purpose of the YoMeta trial is to find out if a psychological therapy called metacognitive therapy (MCT) delivered in a group format is helpful for children and young people experiencing psychological distress due to a mental health disorder (anxiety, stress, or depression).

    More information

As a patient

As a service user, relative or carer using our services, sometimes you may need to turn to someone for help, advice, and support. 

Find resources for carers and service users  Contact the Trust